Comparison of the Efficacy and Safety of Memantal and the Original Drug Memantine in Mild and Moderate Alzheimer’s Disease-Associated Dementia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-09-07

AUTHORS

O. Yu. Shiryaev, D. L. Shapovalov, T. M. Polozova, O. V. Goncharova, N. A. Kuznetsova, E. V. Cherenkova, E. Yu. Fedorova

ABSTRACT

Objective. To carry out a comparative assessment of the clinical efficacy and safety of the original drug memantine and the generic drug (memantal) in patients with mild and moderate dementia in Alzheimer’s disease (AD). Materials and methods. A randomized, controlled, comparative study was performed over a period of six months in 50 patients with mild or moderate AD-associated dementia who had not previously received acetylcholinesterase inhibitors or memantine. The original memantine and memantal were prescribed at a starting dose of 5 mg/day, after which the dose was titrated in accordance with the manufacturer’s recommendations. Patients’ status was evaluated using the MMSE scale, the Cummings NPI questionnaire, and the IADL questionnaire, and side effects were recorded. Results and conclusions. There were no significant differences in the actions of memantal and the original memantine in relation to measures of cognitive functioning, behavioral or psychotic symptoms, or operant activity, and there were no differences in safety. Both study drugs evoked minor improvements in cognitive functions, which were more marked in patients with mild AD-associated dementia than in those with late-onset AD. These results lead to the conclusion that there are no significant differences in the efficacy and safety of the generic (memantal) and the original memantine in patients with mild and moderate AD-associated dementia. More... »

PAGES

799-805

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11055-017-0471-6

DOI

http://dx.doi.org/10.1007/s11055-017-0471-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091607502


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shiryaev", 
        "givenName": "O. Yu.", 
        "id": "sg:person.0651772747.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651772747.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shapovalov", 
        "givenName": "D. L.", 
        "id": "sg:person.0720106147.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720106147.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Polozova", 
        "givenName": "T. M.", 
        "id": "sg:person.0766221347.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766221347.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goncharova", 
        "givenName": "O. V.", 
        "id": "sg:person.01034334547.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034334547.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuznetsova", 
        "givenName": "N. A.", 
        "id": "sg:person.01102447747.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102447747.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cherenkova", 
        "givenName": "E. V.", 
        "id": "sg:person.01150563147.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150563147.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fedorova", 
        "givenName": "E. Yu.", 
        "id": "sg:person.01216676347.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216676347.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00003495-200666110-00015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037466449", 
          "https://doi.org/10.2165/00003495-200666110-00015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40266-015-0266-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025653903", 
          "https://doi.org/10.1007/s40266-015-0266-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-09-07", 
    "datePublishedReg": "2017-09-07", 
    "description": "Objective. To carry out a comparative assessment of the clinical efficacy and safety of the original drug memantine and the generic drug (memantal) in patients with mild and moderate dementia in Alzheimer\u2019s disease (AD). Materials and methods. A randomized, controlled, comparative study was performed over a period of six months in 50 patients with mild or moderate AD-associated dementia who had not previously received acetylcholinesterase inhibitors or memantine. The original memantine and memantal were prescribed at a starting dose of 5 mg/day, after which the dose was titrated in accordance with the manufacturer\u2019s recommendations. Patients\u2019 status was evaluated using the MMSE scale, the Cummings NPI questionnaire, and the IADL questionnaire, and side effects were recorded. Results and conclusions. There were no significant differences in the actions of memantal and the original memantine in relation to measures of cognitive functioning, behavioral or psychotic symptoms, or operant activity, and there were no differences in safety. Both study drugs evoked minor improvements in cognitive functions, which were more marked in patients with mild AD-associated dementia than in those with late-onset AD. These results lead to the conclusion that there are no significant differences in the efficacy and safety of the generic (memantal) and the original memantine in patients with mild and moderate AD-associated dementia.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11055-017-0471-6", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1015474", 
        "issn": [
          "0097-0549", 
          "1573-899X"
        ], 
        "name": "Neuroscience and Behavioral Physiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "keywords": [
      "AD-associated dementia", 
      "Alzheimer's disease", 
      "drug memantine", 
      "late-onset Alzheimer's disease", 
      "significant differences", 
      "starting dose", 
      "study drug", 
      "clinical efficacy", 
      "MMSE scale", 
      "psychotic symptoms", 
      "side effects", 
      "memantine", 
      "patients", 
      "moderate dementia", 
      "dementia", 
      "cognitive function", 
      "IADL questionnaire", 
      "acetylcholinesterase inhibitors", 
      "efficacy", 
      "generic drugs", 
      "cognitive functioning", 
      "disease", 
      "dose", 
      "drugs", 
      "safety", 
      "manufacturer's recommendations", 
      "questionnaire", 
      "conclusion", 
      "symptoms", 
      "mild", 
      "differences", 
      "months", 
      "minor improvements", 
      "recommendations", 
      "operant activity", 
      "inhibitors", 
      "days", 
      "status", 
      "comparative study", 
      "assessment", 
      "period", 
      "functioning", 
      "activity", 
      "study", 
      "action", 
      "measures", 
      "comparative assessment", 
      "effect", 
      "improvement", 
      "results", 
      "function", 
      "comparison", 
      "scale", 
      "accordance", 
      "relation", 
      "method", 
      "materials"
    ], 
    "name": "Comparison of the Efficacy and Safety of Memantal and the Original Drug Memantine in Mild and Moderate Alzheimer\u2019s Disease-Associated Dementia", 
    "pagination": "799-805", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091607502"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11055-017-0471-6"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11055-017-0471-6", 
      "https://app.dimensions.ai/details/publication/pub.1091607502"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_752.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11055-017-0471-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11055-017-0471-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11055-017-0471-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11055-017-0471-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11055-017-0471-6'


 

This table displays all metadata directly associated to this object as RDF triples.

164 TRIPLES      21 PREDICATES      83 URIs      73 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11055-017-0471-6 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N83cdd496fe004726b914f25c4efe9ad8
4 schema:citation sg:pub.10.1007/s40266-015-0266-9
5 sg:pub.10.2165/00003495-200666110-00015
6 schema:datePublished 2017-09-07
7 schema:datePublishedReg 2017-09-07
8 schema:description Objective. To carry out a comparative assessment of the clinical efficacy and safety of the original drug memantine and the generic drug (memantal) in patients with mild and moderate dementia in Alzheimer’s disease (AD). Materials and methods. A randomized, controlled, comparative study was performed over a period of six months in 50 patients with mild or moderate AD-associated dementia who had not previously received acetylcholinesterase inhibitors or memantine. The original memantine and memantal were prescribed at a starting dose of 5 mg/day, after which the dose was titrated in accordance with the manufacturer’s recommendations. Patients’ status was evaluated using the MMSE scale, the Cummings NPI questionnaire, and the IADL questionnaire, and side effects were recorded. Results and conclusions. There were no significant differences in the actions of memantal and the original memantine in relation to measures of cognitive functioning, behavioral or psychotic symptoms, or operant activity, and there were no differences in safety. Both study drugs evoked minor improvements in cognitive functions, which were more marked in patients with mild AD-associated dementia than in those with late-onset AD. These results lead to the conclusion that there are no significant differences in the efficacy and safety of the generic (memantal) and the original memantine in patients with mild and moderate AD-associated dementia.
9 schema:genre article
10 schema:isAccessibleForFree false
11 schema:isPartOf Nd9297b5f2e9645e1aa45f8b5ee90abd1
12 Nf0a1c750253a499ea4382640fae8c1f5
13 sg:journal.1015474
14 schema:keywords AD-associated dementia
15 Alzheimer's disease
16 IADL questionnaire
17 MMSE scale
18 accordance
19 acetylcholinesterase inhibitors
20 action
21 activity
22 assessment
23 clinical efficacy
24 cognitive function
25 cognitive functioning
26 comparative assessment
27 comparative study
28 comparison
29 conclusion
30 days
31 dementia
32 differences
33 disease
34 dose
35 drug memantine
36 drugs
37 effect
38 efficacy
39 function
40 functioning
41 generic drugs
42 improvement
43 inhibitors
44 late-onset Alzheimer's disease
45 manufacturer's recommendations
46 materials
47 measures
48 memantine
49 method
50 mild
51 minor improvements
52 moderate dementia
53 months
54 operant activity
55 patients
56 period
57 psychotic symptoms
58 questionnaire
59 recommendations
60 relation
61 results
62 safety
63 scale
64 side effects
65 significant differences
66 starting dose
67 status
68 study
69 study drug
70 symptoms
71 schema:name Comparison of the Efficacy and Safety of Memantal and the Original Drug Memantine in Mild and Moderate Alzheimer’s Disease-Associated Dementia
72 schema:pagination 799-805
73 schema:productId N46cfd14a8cbf43739d8f275700258ea7
74 Ne891004a96c345fbbd540e605f335fc8
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091607502
76 https://doi.org/10.1007/s11055-017-0471-6
77 schema:sdDatePublished 2022-12-01T06:37
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher Nafddb1dbca064d4fbf478125f4c8f7b7
80 schema:url https://doi.org/10.1007/s11055-017-0471-6
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N028cb8f6803343009b2bd8f2c8ea5f0e rdf:first sg:person.01102447747.44
85 rdf:rest Ned517394446148b1a27b3e2f83ee14d0
86 N38825951b7f7470686c588db7533a731 rdf:first sg:person.0720106147.49
87 rdf:rest Nafa52c2349fb49aa8d41add2b8a55131
88 N46cfd14a8cbf43739d8f275700258ea7 schema:name doi
89 schema:value 10.1007/s11055-017-0471-6
90 rdf:type schema:PropertyValue
91 N83cdd496fe004726b914f25c4efe9ad8 rdf:first sg:person.0651772747.09
92 rdf:rest N38825951b7f7470686c588db7533a731
93 N9a113740069d46caa4c156c6ed54252e rdf:first sg:person.01216676347.10
94 rdf:rest rdf:nil
95 Nafa52c2349fb49aa8d41add2b8a55131 rdf:first sg:person.0766221347.25
96 rdf:rest Nbea4422e94b44226ac31a5786393ab28
97 Nafddb1dbca064d4fbf478125f4c8f7b7 schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 Nbea4422e94b44226ac31a5786393ab28 rdf:first sg:person.01034334547.78
100 rdf:rest N028cb8f6803343009b2bd8f2c8ea5f0e
101 Nd9297b5f2e9645e1aa45f8b5ee90abd1 schema:volumeNumber 47
102 rdf:type schema:PublicationVolume
103 Ne891004a96c345fbbd540e605f335fc8 schema:name dimensions_id
104 schema:value pub.1091607502
105 rdf:type schema:PropertyValue
106 Ned517394446148b1a27b3e2f83ee14d0 rdf:first sg:person.01150563147.80
107 rdf:rest N9a113740069d46caa4c156c6ed54252e
108 Nf0a1c750253a499ea4382640fae8c1f5 schema:issueNumber 7
109 rdf:type schema:PublicationIssue
110 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
111 schema:name Medical and Health Sciences
112 rdf:type schema:DefinedTerm
113 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
114 schema:name Clinical Sciences
115 rdf:type schema:DefinedTerm
116 sg:journal.1015474 schema:issn 0097-0549
117 1573-899X
118 schema:name Neuroscience and Behavioral Physiology
119 schema:publisher Springer Nature
120 rdf:type schema:Periodical
121 sg:person.01034334547.78 schema:affiliation grid-institutes:None
122 schema:familyName Goncharova
123 schema:givenName O. V.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034334547.78
125 rdf:type schema:Person
126 sg:person.01102447747.44 schema:affiliation grid-institutes:None
127 schema:familyName Kuznetsova
128 schema:givenName N. A.
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102447747.44
130 rdf:type schema:Person
131 sg:person.01150563147.80 schema:affiliation grid-institutes:None
132 schema:familyName Cherenkova
133 schema:givenName E. V.
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150563147.80
135 rdf:type schema:Person
136 sg:person.01216676347.10 schema:affiliation grid-institutes:None
137 schema:familyName Fedorova
138 schema:givenName E. Yu.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216676347.10
140 rdf:type schema:Person
141 sg:person.0651772747.09 schema:affiliation grid-institutes:None
142 schema:familyName Shiryaev
143 schema:givenName O. Yu.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651772747.09
145 rdf:type schema:Person
146 sg:person.0720106147.49 schema:affiliation grid-institutes:None
147 schema:familyName Shapovalov
148 schema:givenName D. L.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720106147.49
150 rdf:type schema:Person
151 sg:person.0766221347.25 schema:affiliation grid-institutes:None
152 schema:familyName Polozova
153 schema:givenName T. M.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766221347.25
155 rdf:type schema:Person
156 sg:pub.10.1007/s40266-015-0266-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025653903
157 https://doi.org/10.1007/s40266-015-0266-9
158 rdf:type schema:CreativeWork
159 sg:pub.10.2165/00003495-200666110-00015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037466449
160 https://doi.org/10.2165/00003495-200666110-00015
161 rdf:type schema:CreativeWork
162 grid-institutes:None schema:alternateName Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia
163 schema:name Voronezh Regional Clinical Psychoneurology Dispensary, Voronezh, Russia
164 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...